title: Recognition and management of sleep-disordered breathing in chronic heart failure.
abstract: It is increasingly recognized that sleep-disordered breathing (SDB) is a common modifiable risk factor for cardiovascular disease with significant impact on morbidity and potentially mortality. SDB is highly prevalent in patients with systolic or diastolic heart failure. A high index of suspicion is necessary to diagnose SDB in patients with heart failure because the vast majority of affected patients do not report daytime symptoms. Recent clinical trials have demonstrated improvement in heart function, exercise tolerance, and quality of life after treatment of SDB in patients with heart failure. Accumulating evidence suggests that treatment of SDB should complement the established pharmacologic therapy for chronic heart failure. However, mortality benefit has yet to be demonstrated.
authors.affiliation: Division of Cardiovascular Medicine, Section of Heart Failure and Transplant, Davis Heart/Lung Research Institute, 473 West 12th Avenue, Columbus, OH 43210, USA. Rami.Kahwash@osumc.edu
authors.forename: Rami
authors.initials: R
authors.lastname: Kahwash
authors.forename: Donald
authors.initials: D
authors.lastname: Kikta
authors.forename: Rami
authors.initials: R
authors.lastname: Khayat
mesh_terms: D002908:Chronic Disease; D006333:Heart Failure / Q000150:complications*; D006801:Humans; D012307:Risk Factors; D012891:Sleep Apnea Syndromes / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*